menu
    • menu

    Company profile for Grey Wolf Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Grey Wolf was founded by leading scientists, drug developers and investors committed to delivering next generation oncology therapiesGrey Wolf is a UK and Australian-based drug discovery and development company focused on developing novel immuno-oncology agents. The company was founded in 2017 by experienced industry professionals; Tom McCarthy (Executive Chairman; former President and CEO of Spinifex Pharmaceuticals), and Pet...
    Grey Wolf was founded by leading scientists, drug developers and investors committed to delivering next generation oncology therapiesGrey Wolf is a UK and Australian-based drug discovery and development company focused on developing novel immuno-oncology agents. The company was founded in 2017 by experienced industry professionals; Tom McCarthy (Executive Chairman; former President and CEO of Spinifex Pharmaceuticals), and Peter Joyce (CEO; former Project Leader at Vertex Pharmaceuticals). 

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Grey Wolf Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Milton Park Innovation Centre 99 Park Drive, Milton Park Abingdon, OX14 4RY
    Telephone
    Telephone
    +44 1235 644970
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://greywolftherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Grey Wolf's ERAP1 Inhibitor GRWD5769 First Clinical Data At ASCO
    Grey Wolf's ERAP1 Inhibitor GRWD5769 First Clinical Data At ASCO

    03 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/grey-wolf-therapeutics-presents-first-clinical-data-for-grwd5769-a-first-in-class-erap1-inhibitor-at-the-2024-american-society-for-clinical-oncology-asco-annual-meeting-302161297.html

    PR NEWSWIRE
    03 Jun 2024
    Share Share
    Grey Wolf To Show First ERAP1 Inhibitor GRWD5769 Data At ASCO
    Grey Wolf To Show First ERAP1 Inhibitor GRWD5769 Data At ASCO

    30 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/grey-wolf-therapeutics-to-present-first-clinical-data-for-grwd5769-a-first-in-class-erap1-inhibitor-at-the-2024-american-society-for-clinical-oncology-asco-annual-meeting-302157119.html

    PR NEWSWIRE
    30 May 2024
    Share Share
    Grey Wolf $50M Series B: For Antigen Modulation Tech Expansion
    Grey Wolf $50M Series B: For Antigen Modulation Tech Expansion

    23 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/grey-wolf-therapeutics-closes-oversubscribed-50-million-series-b-financing-expansion-led-by-icg-life-sciences-team-to-accelerate-and-expand-first-of-its-kind-antigen-modulation-technology-302153334.html

    PR NEWSWIRE
    23 May 2024
    Share Share
    Grey Wolf Therapeutics Reports Promising Preclinical Data from Research Collab
    Grey Wolf Therapeutics Reports Promising Preclinical Data from Research Collab

    18 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/grey-wolf-therapeutics-reports-promising-preclinical-data-from-research-collaboration-with-immunocore-in-oral-presentation-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023-301799460.html

    PR NEWSWIRE
    18 Apr 2023
    Share Share
    Grey Wolf Announces Dosing of First Patient in Phase 1/2 Study of GRWD5769
    Grey Wolf Announces Dosing of First Patient in Phase 1/2 Study of GRWD5769

    28 Mar 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/grey-wolf-therapeutics-announces-dosing-of-first-patient-in-phase-12-clinical-study-of-grwd5769-in-patients-with-advanced-solid-tumours-301782519.html

    PR NEWSWIRE
    28 Mar 2023
    Share Share
    Grey Wolf Closes Oversubscribed $49 Million Series B Financing
    Grey Wolf Closes Oversubscribed $49 Million Series B Financing

    26 Jan 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/grey-wolf-therapeutics-closes-oversubscribed-49-million-series-b-financing-to-advance-first-of-its-kind-neoantigen-creation-approaches-301730694.html

    PR NEWSWIRE
    26 Jan 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search